Alternatives to Shift Labs

Develops a point-of-care diagnostic platform for rapid and accurate disease detection.

Leveraging the adaptive immune system to diagnose and treat disease.

Global life sciences company providing diagnostic and biopharma laboratory services.

Femasys is a biomedical company developing minimally invasive, in-office technologies for women's reproductive health, including fertility and permanent birth control solutions.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

Developing novel immunotherapies and diagnostics for cancer.

FIZE Medical is developing a novel, non-invasive device for early detection of neurological diseases.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

Harnessing genetic data for digital insights in rare and germline disorders.

AI-powered breast cancer detection and risk assessment solutions.

Clinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.

Developing ultrasound-mediated nonviral genetic medicines.

Pioneering vision restoration therapies for severe retinal degenerations.

Biopharmaceutical company developing innovative punctal plug technology for eye disease therapies.

Developing novel diagnostics to predict patient response to immunotherapy.

Develops minimally invasive bioelectronic solutions for treating low back pain and spinal degeneration.

Developing novel male contraceptives.

Developing a new histotripsy therapeutic platform for cancer treatment.

Develops and distributes bioreactor technology for stem cell cultivation.